{"id":"69fbe692-f287-41c9-8174-8df0588e7ea7","slug":"fda-de-novo-jnj-ottava-clearance","kind":"regulatory_action","headline":"FDA clears J&J Ottava surgical robot for US launch following de novo submission","summary":"Johnson & Johnson received FDA clearance for its Ottava surgical robot for US launch, following a de novo submission in January 2026 and successful FORTE clinical study results in bariatric surgery. Ottava incorporates four robotic arms into a standard-size surgical table and targets general surgery procedures in the upper abdomen.","occurredAt":"2026-07-22T00:00:00.000Z","reviewStatus":"reviewed","modelId":"97e94523-dc0c-45cf-be22-77e509e09e1b","deploymentId":"da0abbc7-af41-47b9-bd2a-beb526f12be7","companyId":"766676f2-56d0-4910-81dc-03703d6c9c40","dataCenterId":null,"aliases":[],"collisionRisk":"none","reviewNote":null,"severity":"minor","rootCauseCategory":null,"rootCauseDetail":null,"affectedUnitsCount":null,"affectedUnitsBasis":null,"remediationStatus":null,"regulatoryAction":"other","regulatoryBody":"FDA","propertyDamageEstimateUsd":null,"damageEstimateBasis":null,"bodilyInjurySeverity":null,"fatalityCount":null,"lossCostClass":null,"sourceQualityTier":null,"oshaRecordable":null,"oshaCaseNumber":null,"rootCauseDisclosed":null,"publicDisclosureDate":null,"insuranceClaimPublic":null,"formFactor":null,"latitude":null,"longitude":null,"autonomyClass":null,"legalOutcomeClass":"unknown","createdAt":"2026-07-23T14:06:17.141Z","updatedAt":"2026-08-09T05:24:01.599Z","model":{"id":"97e94523-dc0c-45cf-be22-77e509e09e1b","companyId":"766676f2-56d0-4910-81dc-03703d6c9c40","modelName":"Johnson & Johnson Ottava","slug":"ottava-surgical","description":"Next-generation surgical robot in development by J&J/Ethicon. 6-arm configuration, general surgery focus.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.jnj.com/","title":"J&J","date_accessed":"2026-06-07"}],"aliases":[],"collisionRisk":"low","reviewNote":"reverified 2026-06-09 (Kimi-incident remediation): cited primary source resolves and matches manufacturer/reputable domain; relevance adjudicated.","manufacturerTermForTeleop":null,"keyFacts":[{"label":"Product","value":"MONATCH bronchoscopic robot, OTTAVA surgical robotics"},{"label":"Status","value":"Pre-market: FDA De Novo submitted Jan 7 2026; NOT cleared; zero installed base."},{"label":"Stock listing","value":"NYSE: JNJ"},{"label":"Developing division","value":"MedTech/Ethicon"},{"label":"Company type","value":"Global healthcare company"},{"label":"Revenue","value":"\\8B (2025, NYSE: JNJ)"}],"createdAt":"2026-06-08T00:59:22.195Z","updatedAt":"2026-07-12T04:24:54.291Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null},"deployment":{"id":"da0abbc7-af41-47b9-bd2a-beb526f12be7","modelId":"97e94523-dc0c-45cf-be22-77e509e09e1b","versionId":null,"locationId":"8706237d-0d1a-4343-a5a9-e013de231226","operatorId":"766676f2-56d0-4910-81dc-03703d6c9c40","ownerId":null,"slug":"ottava-development-hq","status":"operational","firstSeen":"2024-06-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["surgical_assistance"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"verified_coordinates","deploymentScale":"small_2_10","siteEnvironment":"indoor","operatorType":null,"sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.jnj.com/","title":"J&J","date_accessed":"2026-06-07"}],"notes":"Johnson & Johnson Ottava surgical robot in development phase. No commercial deployment as of 2026. Honest-absence.","keyFacts":[{"label":"Fleet","value":"Johnson & Johnson Ottava surgical robot"},{"label":"Status","value":"In development phase"},{"label":"Start","value":"No commercial deployment as of 2026"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"pilot_lt10","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-06-08T00:59:41.827Z","updatedAt":"2026-08-21T14:23:40.653Z"},"company":{"id":"766676f2-56d0-4910-81dc-03703d6c9c40","name":"Johnson & Johnson","slug":"johnson-and-johnson","description":"Johnson & Johnson (NYSE: JNJ) is a global healthcare and pharmaceutical company with a surgical robotics division that develops the MONARCH platform for bronchoscopic procedures and the OTTAVA surgical robotics system. The company's robotics portfolio spans robotic-assisted surgery, [Digital surgery](/companies/digital-surgery), and minimally invasive interventions.","status":"public","founded":1886,"hq":"New Brunswick, New Jersey, USA","hqLat":40.4936119,"hqLng":-74.4436416,"hqGeocodedAt":"2026-08-05T14:35:14.025Z","hqAddress":null,"hqPrecision":null,"website":"jnj.com","fundingTotal":null,"type":"both","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":54,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.jnj.com/media-center/press-releases/johnson-johnson-submits-ottava-robotic-surgical-system-to-the-u-s-food-and-drug-administration","title":"J&J submits Ottava to FDA (De Novo, Jan 7 2026; 'not authorized to be marketed')","sourceName":"Johnson & Johnson (official)"},{"url":"https://www.medtechdive.com/news/jnj-layoffs-auris-california-robotic/644544/","title":"J&J robotics layoffs + Ottava delays (history/context)","sourceName":"MedTech Dive"},{"url":"https://www.fiercebiotech.com/medtech/jj-to-take-over-verb-surgical-its-robotics-venture-verily","title":"J&J takes over Verb Surgical (Ottava lineage)","sourceName":"FierceBiotech"}],"keyFacts":[{"label":"Product","value":"MONATCH bronchoscopic robot, OTTAVA surgical robotics"},{"label":"Status","value":"Pre-market: FDA De Novo submitted Jan 7 2026; NOT cleared; zero installed base."},{"label":"Stock listing","value":"NYSE: JNJ"},{"label":"Developing division","value":"MedTech/Ethicon"},{"label":"Company type","value":"Global healthcare company"},{"label":"Revenue","value":"\\8B (2025, NYSE: JNJ)"}],"aliases":["J&J","JNJ","J&J MedTech","Ethicon"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"JNJ","stockExchange":"NYSE","secCik":"0000200406","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-03T20:12:18.092Z","updatedAt":"2026-08-21T22:29:28.665Z"},"derived":{"status":"active"},"sources":[{"id":"b9afaacb-7474-4233-8164-c6503235ab23","incidentId":"69fbe692-f287-41c9-8174-8df0588e7ea7","url":"https://firstwordhealthtech.com/story/7767634","label":"FirstWord HealthTech","publishedAt":"2026-07-22T00:00:00.000Z","notes":null,"title":null,"sourceName":"FirstWord HealthTech","mediaType":"article","videoId":null,"channel":null,"durationSec":null,"timestampSec":null,"createdAt":"2026-07-23T14:06:17.141Z","updatedAt":"2026-07-23T14:06:17.141Z"}],"responses":[],"statusEvents":[{"id":"cdaaba3e-8f19-487d-b3fe-e50b4fdc7207","incidentId":"69fbe692-f287-41c9-8174-8df0588e7ea7","status":"active","reason":null,"source":"agent:recon","effectiveAt":"2026-07-23T14:06:18.252Z","createdAt":"2026-07-23T14:06:18.252Z"}],"jsonLd":{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://registry.deploy.report/incidents/fda-de-novo-jnj-ottava-clearance","url":"https://registry.deploy.report/incidents/fda-de-novo-jnj-ottava-clearance","headline":"FDA clears J&J Ottava surgical robot for US launch following de novo submission","description":"Johnson & Johnson received FDA clearance for its Ottava surgical robot for US launch, following a de novo submission in January 2026 and successful FORTE clinical study results in bariatric surgery. Ottava incorporates four robotic arms into a standard-size surgical table and targets general surgery procedures in the upper abdomen.","identifier":"69fbe692-f287-41c9-8174-8df0588e7ea7","datePublished":"2026-07-22T00:00:00.000Z","articleSection":"regulatory action","publisher":{"@id":"https://deploy.report/#organization"},"author":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}